SCHEDULE: Vanguard Divests Entire Avanos Medical Stake

The Vanguard Group has reported a 0% beneficial ownership in Avanos Medical Inc. following an internal realignment, marking a complete divestment of its previously reportable stake.

Summary

• The Vanguard Group has reported a 0% beneficial ownership in Avanos Medical Inc. common stock, down from a previously reportable stake.
• This change is attributed to an internal realignment within The Vanguard Group, Inc. that occurred on January 12, 2026.
• Following this realignment, certain subsidiaries or business divisions of The Vanguard Group, Inc. will now report beneficial ownership separately.
• The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over the securities beneficially owned by such subsidiaries and/or business divisions.
• The event requiring this Amendment No. 13 to Schedule 13G occurred on March 13, 2026.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a moderately negative development for Avanos Medical Inc. due to the complete divestment by a major institutional investor, even if the stated reason is an internal realignment within Vanguard.

Negatives

• The Vanguard Group, a major institutional investor, has reduced its beneficial ownership in Avanos Medical Inc. to 0%, indicating a complete divestment of its previously reportable stake. This could be perceived negatively by the market, even if the stated reason is an internal realignment within Vanguard.

Risks

• Potential negative market perception and investor sentiment for Avanos Medical Inc. due to the complete divestment by a prominent institutional investor like The Vanguard Group.

Industry Context

StockSavvy.ai notes that institutional investor movements, especially from large asset managers like Vanguard, are closely watched. While Vanguard states an internal realignment as the reason, a complete divestment of a reportable stake by such a prominent investor in a medical technology company like Avanos Medical Inc. could signal a shift in investment strategy or a re-evaluation of the company's prospects by that specific reporting entity within Vanguard.

Stakeholder Impact

• Shareholders of Avanos Medical Inc. may react to the news of a major institutional investor divesting its entire reportable stake, potentially leading to negative sentiment or share price pressure.

Key Dates

Recommendation

While the filing attributes the divestment to an internal realignment within The Vanguard Group, the complete exit of a major institutional investor like Vanguard from Avanos Medical Inc. is a notable event. Investors should 'hold' and monitor for further information or market reaction, as this could signal a re-evaluation of the company's investment profile by large funds, even if not explicitly stated as performance-related.

Keywords

Avanos Medical Inc, Vanguard Group, Beneficial Ownership, Schedule 13G, Institutional Investor, Divestment, Common Stock, AVNS